1 / 22

Priority-setting for the Endocrine Disruptor Screening Program: Pesticide Active Ingredients

Priority-setting for the Endocrine Disruptor Screening Program: Pesticide Active Ingredients. Penelope A. Fenner-Crisp Office of Pesticide Programs U.S. Environmental Protection Agency. Food Quality Protection Act Mandates. EPA MUST:

shauna
Download Presentation

Priority-setting for the Endocrine Disruptor Screening Program: Pesticide Active Ingredients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Priority-setting for the Endocrine Disruptor Screening Program:Pesticide Active Ingredients Penelope A. Fenner-Crisp Office of Pesticide Programs U.S. Environmental Protection Agency

  2. Food Quality Protection Act Mandates • EPA MUST: • Screen pesticides (both actives and others) for estrogenic effects that may affect human health • ( may include other effects) • Develop a screening and testing program by August 1998 • Implement the screening and testing program by August 1999 • Report to Congress by August 2000

  3. Proposed Implementation Strategy • Current Size of the Universe • ~~ 950 pesticide active ingredients currently registered in U.S. • ~~ 450 have uses on food/feed • (~~ 2500 “other” ingredients (inerts))

  4. Proposed Implementation Strategy • Proposed elements of the strategy • Issue exemptions • Sort and prioritize “other” (inert) ingredients using the EDPSDB • Revise 40 CFR 158 to include EDSP • Run Pilot program with 25-50 active ingredient substances • Issue orders periodically for groups of substances

  5. Proposed Implementation Strategy • Exemptions- • Issue exemptions for those “biological substance(s) or other substance(s) …. anticipated not to produce any effect in humans similar to an effect produced by a naturally occurring estrogen” or other such endocrine effect…. • Would cover both active and other (inert) ingredients

  6. EPA’s ENDOCRINE DISRUPTOR SCREENING PROGRAM Currently-registered “Other” Ingredients (Inerts) Total Universe of Chemicals Est 87,000 SORT All other Chemicals Polymers Exempted Chemicals Commercial Chemicals < 10,000 lbs Production HTPS Category 1: Hold Category 2: Insufficient Data, Set Priorities for Tier 1 Screening Category 4: Adequate Data Category 3: Need Tier 2 Test Data Tier 1 Screening Tier 2 Testing Hazard Assessment

  7. Proposed Implementation Strategy • Currently-registered Other Ingredients • Formerly known as inerts • Will be sorted for priority along with other substances using the EDPSDB • Special attention will be given to overlap with chemicals also on TSCA inventory, especially those identified for the HPV and Children’s Chemical Evaluation programs

  8. EPA’s ENDOCRINE DISRUPTOR SCREENING PROGRAM To-be-registered Pesticides-Actives and Others Total Universe of Chemicals Est 87,000 SORT All other Chemicals Polymers Exempted Chemicals Commercial Chemicals < 10,000 lbs Production HTPS Category 1: Hold Category 2: Insufficient Data, Set Priorities for Tier 1 Screening Category 4: Adequate Data Category 3: Need Tier 2 Test Data Tier 1 Screening Tier 2 Testing Hazard Assessment

  9. Proposed Implementation Strategy:To-Be-Registered Active and Other Ingredients • Amendment of 40 CFR 158 to include EDSP components • Requirements may vary with class and use pattern, e.g., • Requirements may or may not apply at all • Requirements may be required prospectively or triggered

  10. EPA’s ENDOCRINE DISRUPTOR SCREENING PROGRAM Already-registered Pesticide Actives Total Universe of Chemicals Est 87,000 SORT All other Chemicals Polymers Exempted Chemicals Commercial Chemicals < 10,000 lbs Production HTPS Category 1: Hold Category 2: Insufficient Data, Set Priorities for Tier 1 Screening Category 4: Adequate Data Category 3: Need Tier 2 Test Data Hazard Assessment Tier 1 Screening Tier 2 Testing

  11. Part 158 Toxicology Data Requirements- Human Health Acute oral toxicity Acute dermal Acute inhalation Primary eye irritation Primary dermal irritation Dermal sensitization 2 Subchronic feeding studies 2 Chronic feeding studies 2 Carcinogenicity studies 2 Prenatal developmental toxicity studies Two-generation reproduction study General metabolism study Mutagenicity studies Dermal penetration 21-day dermal toxicity study Subchronic inhalation or dermal study (2 Immunotoxicity studies) Acute or subchronic delayed neurotoxicity Acute neurotoxicity study Subchronic or chronic neurotoxicity Developmental neurotoxicity Scheduled controlled operant behavior Peripheral nerve function Sensory evoked potential

  12. Part 158 Toxicology Data Requirements- Ecological Effects Avian and Mammalian Species Avian oral LD50 Avian dietary LC50 Wild mammal toxicity Avian reproduction Simulated and actual field testing Aquatic Organisms Freshwater fish LC50 Acute LC50 freshwater invertebrates Acute LC50 estuarine and marine organisms Fish early life stage and aquatic invertebrate life cycle Fish life cycle Aquatic organism accumulation Simulated or actual field testing

  13. Already-registered Pesticide Actives Category 3: Need Tier 2 Test Data Category 3/4 Have Adequate Data pre-EDSP, But Need Refinement of Toxicity Profile for EAT Potential Category 4 Adequate Data Tier 2 Testing: 2-Generation Study Designs Tailored testing: Screens Less Comprehensive tests Special Studies Hazard Assessment

  14. PROPOSED SCREENING BATTERY (Tier 1) • In vitro Screens • ER Binding / Reporter Gene Assay • AR Binding / Reporter Gene Assay • Steroidogenesis Assay with minced testis • In vivo Screens • Rodent 3-day Uterotrophic Assay (sc) • Rodent 20-day Pubertal Female Assay with Thyroid • Rodent 5-7 day Hershberger Assay • Frog Metamorphosis Assay • Fish Gonadal Recrudescence Assay

  15. SCREENING BATTERY EXAMPLE 1 • In vitro Screens • ER Binding or Reporter Gene Assay* • AR Binding or Reporter Gene Assay* • Placental aromatase + • Steroidogenesis Assay with minced testis # • In vivo Screens • Rodent 3-day Uterotrophic Assay (sc) • Rodent 20-day Pubertal Male Assay with Thyroid + • Rodent 20-day Pubertal Female Assay w/ Thyroid # • Rodent 5-7 day Hershberger Assay # • Frog Metamorphosis Assay • Fish Reproduction Screening Assay • + Assays inyellowmay replaceassays inred #

  16. SCREENING BATTERY EXAMPLE 2 • In vitro Screens • ER Binding or Reporter Gene Assay* • AR Binding or Reporter Gene Assay* • Steroidogenesis Assay with minced testis # • In vivo Screens • Rodent 3-day Uterotrophic Assay (sc) # • In-utero Assay + • Rodent 20-day Pubertal Female Assay w/ Thyroid # • Rodent 5-7 day Hershberger Assay # • Frog Metamorphosis Assay • Fish Reproduction Screening Assay + Assay inyellow may replace assays inred #

  17. TIER 2 TESTING BATTERY • Multi-generation studies of reproduction and development in: • Mammals • Birds • Fish • Invertebrates • Amphibians

  18. TIER 2 TESTING BATTERY:LESS COMPREHENSIVE TESTS • Alternative or Single-generation studies of reproduction and development in: • Mammals • (Alternative test could be in utero assay described in Screening Battery Example #2) • Birds • Fish • Invertebrates • Amphibians

  19. Proposed Implementation Strategy:Already-Registered Active Ingredients • Original Proposal • Implement EDSP on timetable for FIFRA Reregistration and/or FQPA Tolerance Reassessment mandates

  20. Proposed Implementation Strategy:Already-Registered Active Ingredients • Current Proposal- • Phase 1- Pilot Program with 25-50 “potentially high EAT hazard concern” substances • Later Phases • Periodic issuance of FFDCA Section 408p orders for additional substances • May make use of EDPSDB • May integrate with timetable for Registration Renewal

  21. Proposed Implementation Strategy:Already-Registered Active Ingredients • Selection process for Phase 1 • Will identify chemicals of potential concern • from both a human health and ecological effects perspective • using existing published hazard/risk assessments (e.g., REDs), internal databases, Data Evaluation Records (i.e., study reviews), open literature and expert scientific judgment

  22. Summary:Proposed Implementation Strategy • Issue exemptions • Sort and prioritize “other” (inert) ingredients using EDPSDB • Revise 40 CFR 158 to include EDSP (for to-be-registered substances) • Run Pilot program for 25-50 (already-registered) active ingredient substances • Issue orders periodically for groups of (already-registered) substances

More Related